Ā | All patients | Men with PCa | Prostatectomy cohort |
---|---|---|---|
Men, no. | 101 | 41 (40.6) | 26 (25.7) |
Age, year | 68.9āĀ±ā8.1 | 67.8āĀ±ā8.0 | 65.2āĀ±ā7.2 |
PSA, ng/ml | 10.8āĀ±ā6.1 | 11.3āĀ±ā6.3 | 11.2āĀ±ā6.3 |
Prostate volume, ml | 42.1āĀ±ā15.3 | 39.4āĀ±ā13.6 | 35.1āĀ±ā11.8 |
Prior negative biopsy, no. | 1.5āĀ±ā0.7 | 1.4āĀ±ā0.6 | 1.4āĀ±ā0.6 |
MRI lesions per patient, no. | 1.9āĀ±ā1.0 | 2.1āĀ±ā1.1 | 2.4āĀ±ā1.0 |
PI-RAD score, no. (%) | |||
ā2 | 13 (12.9) | 1 (1.0) | 0 (0) |
ā3 | 31 (30.7) | 3 (3.0) | 0 (0) |
ā4 | 36 (35.6) | 19 (18.8) | 12 (11.9) |
ā5 | 21 (20.8) | 18 (17.8) | 14 (13.9) |
TB cores per patiens | 4.2āĀ±ā1.5 | 4.8āĀ±ā1.6 | 4.9āĀ±ā1.8 |
Insignificant PCa | - | 16 (15.8) | 6 (5.9) |
Significant PCa | - | 25 (24.8) | 20 (19.8) |
Gleason score, no. (%) | |||
āGleason 6 | - | 17 (16.8) | 6 (5.9) |
āGleason 7 (3Ā +Ā 4) | - | 9 (8.9) | 8 (7.9) |
āGleason 7 (4Ā +Ā 3) | - | 7 (6.9) | 5 (5.0) |
āGleason ā„8 | - | 8 (7.9) | 7 (6.9) |